EUVIMEDEUVIMED entdecken
Crossref

The molecular and genetic view of tauopathies: From structural polymorphism to systemic neurodegeneration

Esra Demir Ünal, Selim Selçuk Çomoğlu

Journal of Parkinson's Disease and Movement Disorders · 29.07.2026 · 29 (2) · 33-45

DOI: 10.5606/phhb.dergisi.2026.66 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Parkinson's Disease and Movement Disorders, online erschienen am 29.07.2026. Verfasst von Esra Demir Ünal und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tauopathies constitute a broad group of clinically heterogeneous neurodegenerative disorders, including Alzheimer’s disease, progressive supranuclear palsy, and Pick’s disease, characterized by abnormal metabolism, misfolding, and intracellular aggregation of the microtubule-associated protein tau. These diseases are defined by disruptions in alternative splicing of the tau protein, toxic post-translational modifications such as hyperphosphorylation and acetylation, and the “prion-like” spread of pathological tau seeds across anatomically connected regions. Recent cryogenic electron microscopy studies have demonstrated that each tauopathy has a unique filament-folding structure, elucidating the molecular basis of phenotypic variation among diseases. The aim of this review is to provide a holistic perspective by synthesizing recent developments in the molecular and genetic architecture of tauopathies, particularly newly discovered genetic risk loci and cellular proteostasis mechanisms. In this context, detailing the process from the physiological functions of the tau protein to its pathological transformation aims to analytically evaluate the diagnostic value of fluid biomarkers and current data on next-generation clinical-stage therapeutic strategies, such as monoclonal antibodies and antisense oligonucleotides.

Zitieren

APA

Ünal, E. D., & Çomoğlu, S. S. (2026). The molecular and genetic view of tauopathies: From structural polymorphism to systemic neurodegeneration. Journal of Parkinson's Disease and Movement Disorders, 29(2), 33-45. https://doi.org/10.5606/phhb.dergisi.2026.66

Vancouver

Ünal ED, Çomoğlu SS. The molecular and genetic view of tauopathies: From structural polymorphism to systemic neurodegeneration. Journal of Parkinson's Disease and Movement Disorders. 2026;29(2):33-45. doi:10.5606/phhb.dergisi.2026.66

BibTeX
@article{nal2026,
  author = {Ünal, Esra Demir and Çomoğlu, Selim Selçuk},
  title = {The molecular and genetic view of tauopathies: From structural polymorphism to systemic neurodegeneration},
  journal = {Journal of Parkinson's Disease and Movement Disorders},
  year = {2026},
  volume = {29},
  number = {2},
  pages = {33--45},
  doi = {10.5606/phhb.dergisi.2026.66}
}
Kostenlos starten →